Verrica Pharmaceuticals Inc. (VRCA) DCF Valuation
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Verrica Pharmaceuticals Inc. (VRCA) Bundle
Enhance your investment strategies with the Verrica Pharmaceuticals Inc. (VRCA) DCF Calculator! Explore authentic Verrica financials, adjust growth projections and expenses, and instantly observe how modifications affect the intrinsic value of Verrica Pharmaceuticals Inc. (VRCA).
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | 12.0 | 9.0 | 5.1 | 4.3 | 3.5 | 2.9 | 2.4 | 2.0 |
| Revenue Growth, % | 0 | 0 | 0 | -24.73 | -43.27 | -17 | -17 | -17 | -17 | -17 |
| EBITDA | -30.1 | -39.4 | -30.3 | -21.6 | -62.2 | -.9 | -.7 | -.6 | -.5 | -.4 |
| EBITDA, % | 100 | 100 | -252.61 | -239.12 | -1213.84 | -20 | -20 | -20 | -20 | -20 |
| Depreciation | .3 | .2 | .5 | .7 | .8 | 1.9 | 1.6 | 1.3 | 1.1 | .9 |
| Depreciation, % | 100 | 100 | 3.93 | 7.95 | 16.32 | 45.64 | 45.64 | 45.64 | 45.64 | 45.64 |
| EBIT | -30.3 | -39.7 | -30.8 | -22.3 | -63.0 | -.9 | -.7 | -.6 | -.5 | -.4 |
| EBIT, % | 100 | 100 | -256.54 | -247.07 | -1230.15 | -20 | -20 | -20 | -20 | -20 |
| Total Cash | 62.0 | 65.5 | 70.4 | 34.3 | 69.5 | 4.3 | 3.5 | 2.9 | 2.4 | 2.0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .5 | 4.4 | 2.5 | 2.1 | 1.7 | 1.4 | 1.2 |
| Account Receivables, % | 100 | 100 | 0 | 5.39 | 86.18 | 58.31 | 58.31 | 58.31 | 58.31 | 58.31 |
| Inventories | .0 | .0 | .0 | -.5 | 1.0 | 1.8 | 1.5 | 1.3 | 1.0 | .9 |
| Inventories, % | 100 | 100 | 0 | -5.39 | 19.95 | 42.91 | 42.91 | 42.91 | 42.91 | 42.91 |
| Accounts Payable | 1.2 | .3 | .8 | .5 | 2.5 | 2.2 | 1.8 | 1.5 | 1.3 | 1.1 |
| Accounts Payable, % | 100 | 100 | 7.04 | 5.61 | 48.09 | 52.15 | 52.15 | 52.15 | 52.15 | 52.15 |
| Capital Expenditure | -.7 | -1.5 | -.9 | -.3 | -.4 | -.2 | -.1 | -.1 | -.1 | -.1 |
| Capital Expenditure, % | 100 | 100 | -7.36 | -3.34 | -7.06 | -3.55 | -3.55 | -3.55 | -3.55 | -3.55 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -30.1 | -42.3 | -34.1 | -25.2 | -63.0 | -.8 | -.7 | -.6 | -.5 | -.4 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -29.3 | -44.3 | -34.1 | -25.1 | -66.0 | 1.8 | 1.1 | .9 | .8 | .6 |
| WACC, % | 9.72 | 9.77 | 9.77 | 9.77 | 9.77 | 9.76 | 9.76 | 9.76 | 9.76 | 9.76 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 4.3 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 1 | |||||||||
| Terminal Value | 9 | |||||||||
| Present Terminal Value | 5 | |||||||||
| Enterprise Value | 10 | |||||||||
| Net Debt | -24 | |||||||||
| Equity Value | 34 | |||||||||
| Diluted Shares Outstanding, MM | 45 | |||||||||
| Equity Value Per Share | 0.74 |
What You Will Get
- Comprehensive VRCA Financials: Access to historical and projected data for precise valuation.
- Customizable Variables: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Real-Time Calculations: Intrinsic value and NPV are calculated automatically and updated dynamically.
- Scenario Analysis: Evaluate various scenarios to assess Verrica's future performance.
- User-Friendly Interface: Designed for industry experts while remaining approachable for newcomers.
Key Features
- Comprehensive Data: Verrica Pharmaceuticals Inc.'s historical financials and anticipated forecasts.
- Customizable Parameters: Adjust inputs such as WACC, tax rates, revenue growth, and EBITDA margins.
- Real-Time Insights: View the intrinsic value of Verrica Pharmaceuticals Inc. recalculated instantly.
- Intuitive Visualizations: Dashboard charts present valuation outcomes and essential metrics.
- Designed for Precision: A professional-grade tool tailored for analysts, investors, and finance professionals.
How It Works
- Download the Template: Gain immediate access to the Excel-based VRCA DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and additional parameters.
- Instant Calculations: The model automatically recalculates Verrica Pharmaceuticals' intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the outcomes to inform your investment or financial strategy.
Why Choose This Calculator for Verrica Pharmaceuticals Inc. (VRCA)?
- Accuracy: Utilizes real Verrica financial data to ensure precise calculations.
- Flexibility: Allows users to easily test and adjust inputs according to their needs.
- Time-Saving: Avoid the complexities of creating a financial model from the ground up.
- Professional-Grade: Crafted with the expertise and precision expected at the CFO level.
- User-Friendly: Designed for simplicity, making it accessible for users with varying levels of financial knowledge.
Who Should Use This Product?
- Investors: Accurately assess Verrica Pharmaceuticals Inc.'s (VRCA) fair value prior to making investment choices.
- CFOs: Utilize a professional-grade DCF model for comprehensive financial reporting and analysis.
- Consultants: Easily customize the template for client valuation reports related to Verrica Pharmaceuticals Inc. (VRCA).
- Entrepreneurs: Acquire knowledge on financial modeling practices employed by leading pharmaceutical companies.
- Educators: Implement it as a teaching resource to illustrate valuation techniques in the pharmaceutical sector.
What the Template Contains
- Pre-Filled DCF Model: Verrica Pharmaceuticals Inc. (VRCA)’s financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Verrica Pharmaceuticals Inc. (VRCA)’s profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.